Fuente: Fortune
A new radar developed with the Gates Foundation and Wellcome Leap reveals that fewer than 3% of clinical trials are women-specific.
Leer en la Fuente
Noticias Relacionadas
Lista de Noticias
Fuente: Fortune
A new radar developed with the Gates Foundation and Wellcome Leap reveals that fewer than 3% of clinical trials are women-specific.